Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
ProImmune Introduces ProT2 MHC Class II Tetramer Reagents
Thursday, January 14, 2016
ProImmune has announced the introduction of ProT2TM, a range of Human MHC Class II tetramer reagents for tetramer analyses in the study of antigen-specific CD4+ T cell immune responses.
High Integrity Storage of Larger Sample Volumes
Saturday, December 19, 2015
High quality storage tubes provide an ideal solution for storing larger volumes.
Olink Bioscience Introduces a New 92-protein Biomarker Panel
Friday, December 18, 2015
Proseek® Multiplex Oncology II96x96 for oncology research.
Sample Preparation for LC/MS
Tuesday, December 15, 2015
Sample evaporators and microplate products range from Porvair.
Scaling Up Screening in 96- & 384-Well Microplates
Wednesday, December 09, 2015
Researchers are using VIAFLO II electronic pipettes to scale-up their screening of venoms and small compounds.
Novel EKF Biomarker Identifies People Likely to Develop Diabetic Nephropathy
Wednesday, December 02, 2015
New data paves way for adoption of sTNFR1 as a routine test for Diabetic Nephropathy management.
Olympus Puts Well Plate Imaging into Focus
Friday, November 27, 2015
Olympus introduces its new Z-Drift Compensation IX3-ZDC2 system and updated cellSens software, for enhanced live cell and multi well plate imaging.
The New Gold Standard Microplate Reader for High Throughput Screening BMG LABTECH Introduces its New Product PHERAstar® FSX at SLAS 2016
Thursday, November 12, 2015
Visitors at the SLAS in San Diego will witness the international premiere of the new reference multi-mode HTS reader PHERAstar® FSX.
Nanion’s SyncroPatch is Preferred Technology for Patch Clamp-Based HTS
Wednesday, November 04, 2015
SyncroPatch 384/768PE allows the screening of compound libraries of >100,000 substances.
Showing Results 51 - 60 of 2763
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,200+ scientific and medical posters
4,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!